The evidence does not show that supplying extra methionine, inositol and choline by injection to a patient who is not deficient produces weight loss on its own
Mechanism of Action of GLP-1 / GIP (Zepbound) Medication
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
AOD-9604s selective action on lipid metabolism while preserving glucose homeostasis allows individuals to maintain their normal eating patterns without the reactive hunger that follows blood sugar destabilization
If levels plateau or decline, your provider may adjust frequency, dose, or investigate underlying absorption issues such as pernicious anemia, metformin use, or gastrointestinal conditions
Glow contains BPC-157, TB-500, and GHK-Cu (70mg total)
